Please refer to the Summary of Product Characteristics (SmPC) for full details of Prescribing Information.
Sudosalve (dibrompropamidine isetionate) nappy rash treatment 0.15%w/w cream Abbreviated Prescribing Information.
Presentation: Smooth white cream. Indications: Treatment of nappy rash. Dosage and administration: For cutaneous use. Adults: apply to the affected area, either directly or on a light dressing, two or three times a day. Elderly and children: no specific recommendations. Renal and hepatic impairment: no data. Contraindications: Should not be used in patients with known hypersensitivity to dibrompropamidine or any of the other ingredients. Precautions and warnings: Prolonged use may interfere with healing and cause skin necrosis in infants. Contains the following excipients: methyl parahydroxybenzoate (E218) which may cause allergic reactions (possibly delayed); castor oil which may cause skin reactions; cetostearyl alcohol which may cause local skin reactions. Interactions: None known. Pregnancy and lactation: Avoid unless considered essential. Effects on ability to drive and use machines: None. Adverse reactions: May cause a sensitisation reaction or contact dermatitis. Treatment should be discontinued immediately. Overdose: No toxic effects are likely to occur if ingested. Price: 25g tube: £5.99. Legal category: GSL. Marketing Authorisation Number: PL 14251/0128. Marketing Authorisation Holder: Manx Healthcare Ltd, Taylor Group House, Wedgnock Lane, Warwick, CV34 5YA. United Kingdom. Job Code: MED-GB-00011. Date of Preparation: January 2021.
